ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease
Madan Jagasia, Aleksandr Lazaryan, Carlos R. Bachier, Amandeep Salhotra, Daniel J. Weisdorf, Behyar Zoghi, James Essell, Laurie Green, Olivier Schueller, Jeegar Patel, Alexandra Zanin-Zhorov, Jonathan M. Weiss, Zhongming Yang, David Eiznhamer, Sanjay K. Aggarwal, Bruce R. Blazar, Stephanie J. Lee
Dive into the research topics of 'ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease'. Together they form a unique fingerprint.